» Authors » Gregory P Hess

Gregory P Hess

Explore the profile of Gregory P Hess including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 350
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Ahn J, Bae S, Joseph C, Schnitzler M, Hess G, et al.
Clin J Am Soc Nephrol . 2023 Jan; 18(1):91-98. PMID: 36719161
Background: Gabapentinoids, commonly used for treating neuropathic pain, may be misused and coprescribed with opioid and benzodiazepine, increasing the risk of mortality and dependency among kidney transplant recipients. Methods: We...
2.
Acquavella J, Vago E, Sorensen H, Horvath-Puho E, Hess G
BMJ Open Respir Res . 2022 Dec; 9(1). PMID: 36549785
Objective: To estimate the prevalence of diagnosed alpha-1 antitrypsin deficiency (dAATD) in Denmark as of 31 December 2018, and dAATD incidence and mortality from 1 January 2000 to 31 December...
3.
Kuppachi S, Cheungpasitporn W, Li R, Caliskan Y, Schnitzler M, McAdams-DeMarco M, et al.
Kidney Med . 2022 Jun; 4(6):100474. PMID: 35669410
Rationale & Objective: Disorders of bone and mineral metabolism frequently develop with advanced kidney disease, may be exacerbated by immunosuppression after kidney transplantation, and increase the risk of fractures. Study...
4.
Axelrod D, Cheungpasitporn W, Bunnapradist S, Schnitzler M, Xiao H, McAdams-DeMarco M, et al.
Kidney Med . 2022 Jan; 4(1):100377. PMID: 35072042
Rationale & Objective: Posttransplant diabetes mellitus (DM) after kidney transplantation increases morbidity and mortality, particularly in older and obese recipients. We aimed to examine the impact of immunosuppression selection on...
5.
Ahn J, Bae S, Schnitzler M, Hess G, Lentine K, Segev D, et al.
Transplant Direct . 2021 Dec; 8(1):e1260. PMID: 34912947
Background: Posttransplant diabetes (PTD), a major complication after kidney transplantation (KT), is often attributable to immunosuppression. The risk of PTD may increase with more potent steroid maintenance and older recipient...
6.
Ahn J, Bae S, Chu N, Wang L, Kim J, Schnitzler M, et al.
Transplant Direct . 2021 Sep; 7(7):e715. PMID: 34476294
Background: Among adult kidney transplant (KT) recipients, the risk of post-KT adverse outcomes differs by type of induction immunosuppression. Immune response to induction differs as recipients age; yet, choice of...
7.
Lentine K, Salvalaggio P, Caliskan Y, Lam N, McAdams-DeMarco M, Axelrod D, et al.
J Heart Lung Transplant . 2021 Apr; 40(6):513-524. PMID: 33846078
Background: Prescription opioid and benzodiazepine use have been associated with morbidity and mortality among some groups of solid organ transplant recipients, but implications for outcomes among lung transplant patients are...
8.
Givertz M, Yang M, Hess G, Zhao B, Rai A, Butler J
ESC Heart Fail . 2021 Mar; 8(3):1915-1923. PMID: 33689217
Aims: The aim of this study is to characterize healthcare resource utilization and costs in patients with heart failure with reduced ejection fraction (HFrEF) following a worsening heart failure event....
9.
Lentine K, Cheungpasitporn W, Xiao H, McAdams-DeMarco M, Lam N, Segev D, et al.
Transplantation . 2020 Nov; 105(8):1840-1849. PMID: 33214534
Background: Although the population of older transplant recipients has increased dramatically, there are limited data describing the impact of immunosuppression regimen choice on outcomes in this recipient group. Methods: National...
10.
Lentine K, Lam N, Caliskan Y, Alhamad T, Xiao H, Schnitzler M, et al.
Clin Transplant . 2020 Oct; 34(12):e14118. PMID: 33048372
Hydroxychloroquine (HCQ) is an antimalarial drug with immunomodulatory effects used to treat systemic lupus erythematosus (SLE) and scleroderma. The antiviral effects of HCQ have raised attention in the context of...